Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02214849 · ClinicalTrials.gov registry record · NA
LATCH: Lactation Advice Thru Texting Can Help
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 249
- Enrollment target
NCT02214849: Completed NA study, sponsored by Yale University.
NCT02214849 is a NA study that has completed, run by Yale University. The registered enrollment target is 249 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02214849, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 249 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if a two-way texting platform to be used as an adjunct tool for breastfeeding peer counselors can improve breastfeeding behaviors among women enrolled in the WIC program in Connecticut. The hypothesis of the study is that providing additional information and support through text messaging starting in pregnancy and continuing after the birth of the child will increase exclusive breastfeeding rates during the first six months of life.
Interventions
- BEHAVIORAL LATCH Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT02214849 record still lists
NCT02214849 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which LATCH Intervention is the first listed.
NCT02214849 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02214849 about?
NCT02214849 is a clinical study titled "LATCH: Lactation Advice Thru Texting Can Help". The purpose of this study is to find out if a two-way texting platform to be used as an adjunct tool for breastfeeding peer counselors can improve breastfeeding behaviors among women enrolled in the WIC program in Connecticut. The hypothesis of the study is that providing additional information and ...
What is the current status of trial NCT02214849?
This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2014-08. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02214849?
The interventions under investigation include: LATCH Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02214849?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02214849's enrollment target sits among peer trials
249 434th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia